Atherosclerotic stenosis of lower extremity arteries — claudication, ABI ≤0.90, optimized with antiplatelet, statin, exercise.
Also known as: PAD, PVD, peripheral arterial disease, claudication, critical limb ischemia
Overview
Atherosclerotic narrowing of the peripheral arteries, most commonly the lower extremities, producing exertional pain (claudication) or, in severe cases, rest pain, tissue loss, and limb-threatening ischemia.
Epidemiology
Affects ~10-15% of adults over 65 in the US. Strongly associated with coronary and cerebrovascular disease; PAD patients have markedly elevated risk of MI and stroke.
Try two board-style Peripheral Arterial Disease questions
Real questions from the FirstPassPA bank, with the full explanation. Pick an answer — no signup, no email.
Question 1CardiovascularMedium
A 72-year-old man with a 40-pack-year smoking history reports cramping pain in both calves that comes on after walking two blocks and resolves within a few minutes of rest. Pedal pulses are diminished bilaterally, the feet are cool, and there is loss of hair over the shins. There are no ulcers and no rest pain. The ankle-brachial index is 0.62. Which of the following is the most appropriate first-line therapy?
APentoxifylline for claudication relief
BSurgical revascularization with bypass
CIntravenous heparin for anticoagulation
DSupervised exercise and antiplatelet
ETherapeutic anticoagulation with warfarin
Reveal answer & full explanation
Correct answer: D — Supervised exercise and antiplatelet
APentoxifylline for claudication relief
BSurgical revascularization with bypass
CIntravenous heparin for anticoagulation
DSupervised exercise and antiplatelet✓
ETherapeutic anticoagulation with warfarin
Why Supervised exercise and antiplatelet is correct
Calf cramping reproducibly brought on by walking and relieved by rest, with diminished pulses, cool feet, shin hair loss, and an ankle-brachial index of 0.62 (an ABI of 0.90 or less is abnormal), is intermittent claudication from peripheral artery disease.
First-line therapy is a supervised/structured exercise program plus antiplatelet therapy (aspirin or clopidogrel) and a high-intensity statin, with aggressive smoking cessation and risk-factor control (per ACC/AHA peripheral artery disease guidance).
Cilostazol may be added to improve walking distance when symptoms persist.
Why the others are wrong
Therapeutic anticoagulation with warfarin — does not treat atherosclerotic claudication and adds bleeding risk without improving limb outcomes. Trap: confusing arterial atherosclerosis with thromboembolic disease.
Intravenous heparin for anticoagulation — reserved for acute limb ischemia (sudden pain, pallor, pulselessness), which this stable exertional picture is not. Trap: anchoring on 'vascular leg' and over-escalating.
Surgical revascularization with bypass — reserved for functionally limiting claudication with an inadequate response to guideline-directed medical therapy that includes structured exercise, or for chronic limb-threatening ischemia (more than 2 weeks of ischemic rest pain, a nonhealing wound, or gangrene); this untreated patient without rest pain or tissue loss has neither. Trap: jumping to invasive therapy before exercise and medical therapy have been tried.
Pentoxifylline for claudication relief — an older hemorheologic drug once prescribed for claudication, but its effect on walking distance is small and inconsistent (no better than placebo in a head-to-head trial against cilostazol), and current ACC/AHA PAD guidance recommends against it as providing no benefit; cilostazol is the agent added when symptoms persist. Trap: reaching for a superseded drug instead of exercise and antiplatelet therapy.
Additional high-yield points
Chronic limb-threatening ischemia (the term that replaced "critical limb ischemia") is defined clinically: more than 2 weeks of ischemic rest pain, a nonhealing wound or ulcer, or gangrene due to objectively proven arterial disease. No ABI cutoff defines it, so a low ABI alone is not an indication for revascularization.
Resting ABI is reported as abnormal (0.90 or less), borderline (0.91-0.99), normal (1.00-1.40) or noncompressible (above 1.40).
Full-intensity oral anticoagulation is not used in PAD without another indication such as atrial fibrillation, but low-dose rivaroxaban 2.5 mg twice daily plus low-dose aspirin is a guideline option to reduce major cardiovascular and limb events in symptomatic PAD.
Question 2CardiovascularMedium
A 66-year-old man with peripheral artery disease and an ankle-brachial index of 0.55 one year ago returns with 2 months of progressively severe right foot pain that now occurs at rest, worsens with leg elevation, and improves when he dangles the foot over the bedside. He has a non-healing ulcer on the right great toe. He has no diabetes. The right foot is cool with absent pedal pulses. Repeat ankle-brachial index is 0.32. Which of the following is the most likely diagnosis?
AChronic limb-threatening ischemia
BIntermittent claudication
CNeuropathic ulceration
DVenous stasis ulceration
EAcute thrombotic limb ischemia
Reveal answer & full explanation
Correct answer: A — Chronic limb-threatening ischemia
AChronic limb-threatening ischemia✓
BIntermittent claudication
CNeuropathic ulceration
DVenous stasis ulceration
EAcute thrombotic limb ischemia
Why Chronic limb-threatening ischemia is correct
Chronic limb-threatening ischemia (CLTI), the term that replaced critical limb ischemia in the 2024 ACC/AHA multisociety peripheral artery disease (PAD) guideline, is a clinical diagnosis: more than 2 weeks of ischemic rest pain, a nonhealing wound or ulcer, or gangrene attributable to objectively proven arterial occlusive disease.
He has two qualifying features: foot pain that has progressed over 2 months to pain at rest, and a nonhealing great-toe ulcer. His low ankle-brachial index (ABI) of 0.32, down from 0.55, supports objectively proven arterial occlusive disease, but no ABI value defines CLTI.
Ischemic rest pain typically affects the forefoot, worsens with limb elevation, and is relieved by dependency, which is why he dangles the foot over the bedside.
Timely treatment is essential: surgical, endovascular, or hybrid revascularization is recommended when feasible to minimize tissue loss, heal wounds, relieve pain, and preserve a functional limb, coordinated with wound care by a multispecialty care team.
Why the others are wrong
Venous stasis ulceration — venous ulcers typically sit over the medial malleolus, hurt less with leg elevation, and occur with palpable pulses and a normal ABI; each of those features is reversed here (trap: buzzword-matching "leg ulcer" to the most common ulcer type)
Intermittent claudication — claudication is exertional pain relieved by rest; pain at rest plus tissue loss means the disease has progressed beyond claudication (trap: premature closure on his previously known PAD stage)
Neuropathic ulceration — neuropathic ulcers are typically painless, occur over plantar pressure points, and usually accompany diabetes, which he does not have; his foot has severe rest pain and absent pulses (trap: confused-with-diabetic-foot-ulcer)
Acute thrombotic limb ischemia — a diseased artery in known PAD can thrombose suddenly and threaten the limb, but acute limb ischemia is defined by symptoms of less than 2 weeks, usually of abrupt onset; his 2-month progression to rest pain and a nonhealing ulcer is chronic (trap: separating acute from chronic limb-threatening ischemia by severity rather than duration)
Additional high-yield points
Symptom duration separates CLTI (more than 2 weeks) from acute limb ischemia (less than 2 weeks).
A normal or near-normal ABI does not exclude CLTI: the ABI is 0.90-1.40 in nearly one-quarter of patients with CLTI, so it is reasonable to add toe pressure/toe-brachial index (TBI) with waveforms, transcutaneous oxygen pressure, or skin perfusion pressure when CLTI is suspected.
Historically, CLTI carried a 1-year amputation rate of up to 30% and a 1-year mortality rate of 25%-35%.
That's 2. Get 7,700+ more.
Unlock the full FirstPassPA bank: 7,700+ board-style questions, flashcards, and an AI tutor that explains every answer. Your 7-day free trial includes everything, and there's no credit card required.
You've read your 2 free diagnosis previews. Create your free account to unlock the full Peripheral Arterial Disease (PAD) outline — plus all 514 diagnoses, 7,700+ board-style questions, flashcards, and an AI tutor. Your 7-day free trial includes everything, and there's no credit card required.
Atherosclerotic plaque progressively narrows lower extremity arteries. With exertion, demand exceeds the stenosis-limited supply, producing ischemic muscle pain that resolves with rest. Chronic limb-threatening ischemia (CLTI) occurs when resting perfusion is inadequate to maintain tissue viability — manifesting as rest pain, non-healing ulcers, or gangrene.
Clinical presentation
Symptoms
Intermittent claudication — cramping, aching, or fatigue in calf, thigh, or buttock with exertion, relieved within 10 minutes of rest
Distance to symptom onset reproducible
Rest pain — burning pain in forefoot at night, relieved by hanging foot off bed (gravity-assisted perfusion)
Ulcers — typically dry, punched-out, on toes, lateral malleolus, or pressure points (contrast with venous ulcers)
Bruits over femoral or iliac arteries
Differential diagnosis
Spinal stenosis (neurogenic claudication) — Pain worse with standing/lumbar extension, relieved by sitting or leaning forward; no improvement with rest while standing; normal pulses
Venous claudication — Bursting calf pain after walking, relieved by elevation; history of DVT; signs of chronic venous insufficiency
Deep vein thrombosis — Unilateral leg swelling, warmth, tenderness, Homan sign; D-dimer and duplex US; massive iliofemoral DVT (phlegmasia cerulea dolens) gives a swollen, tense, cyanotic leg, unlike the pale, cold, pulseless leg of acute limb ischemia
Compartment syndrome — Pain out of proportion, paresthesia, pallor, paralysis after trauma or exertion (chronic exertional compartment syndrome)
Popliteal artery entrapment — Young athlete with calf claudication; pulses disappear with plantar flexion; MRA diagnostic
Atheroembolism (blue toe syndrome) — Cholesterol emboli from aortic plaque, often after catheterization: painful blue toes and livedo reticularis with palpable pedal pulses, unlike the pulseless limb of acute limb ischemia
Diagnostic workup
Diagnostic criteria
ABI ≤0.90 at rest is diagnostic of PAD. The 2024 ACC/AHA guideline does not grade PAD as mild, moderate, or severe by ABI. Chronic limb-threatening ischemia (CLTI, formerly critical limb ischemia) is a clinical diagnosis: ischemic rest pain, a non-healing wound, or gangrene for >2 weeks due to objectively confirmed PAD; very low ankle or toe pressures (e.g., ankle <50 mmHg, toe <30 mmHg) support it, but no ABI cutoff defines it, and calcified vessels in diabetes or CKD can give a falsely reassuring ABI.
Ankle-brachial index (ABI) — initial test; normal 1.00-1.40, borderline 0.91-0.99, abnormal ≤0.90
Toe-brachial index (TBI) if ABI >1.40 (non-compressible vessels — diabetes, CKD)
Exercise treadmill ABI if exertional leg symptoms with normal or borderline resting ABI (0.91-1.40) — measured 1-5 min post-exercise; a significant fall from resting confirms PAD
Duplex ultrasound to localize lesions
CT angiography or MR angiography for anatomic mapping before intervention
Catheter angiography — gold standard, usually combined with intervention
Diagnostic algorithm
Resting ABI
Interpretation (2024 ACC/AHA)
>1.40
Noncompressible (calcified) vessels; use toe-brachial index (TBI ≤0.70 is abnormal)
1.00-1.40
Normal; exertional leg symptoms → exercise treadmill ABI
0.91-0.99
Borderline; exertional leg symptoms → exercise treadmill ABI
≤0.90
Abnormal; establishes PAD (no mild/moderate/severe grading by ABI)
Resting ankle-brachial index categories (2024 ACC/AHA PAD guideline). Chronic limb-threatening ischemia is a clinical diagnosis (rest pain >2 weeks, nonhealing wound or gangrene), not an ABI cutoff.
Treatment
First-line
SMOKING CESSATION — single most important intervention; nicotine replacement, varenicline, bupropion, counseling
Supervised exercise therapy — 30-45 min walking 3+ times per week; superior to most pharmacotherapy for claudication distance
High-intensity statin (atorvastatin 40-80 mg or rosuvastatin 20-40 mg) — LDL-C goal <55 mg/dL if very high risk (symptomatic PAD plus another major ASCVD event or multiple high-risk conditions such as age ≥65, diabetes, or hypertension, which describes most PAD patients), otherwise <70 mg/dL, per the 2026 ACC/AHA dyslipidemia guideline; add ezetimibe or a PCSK9 inhibitor if above goal on a maximally tolerated statin
Rivaroxaban 2.5 mg PO BID + aspirin 81 mg daily (COMPASS trial) — for symptomatic PAD to reduce MACE and major adverse limb events
Diabetes control (A1c <7%), blood pressure control (<130/80, ACEi/ARB preferred)
Foot care education for diabetics — daily inspection, properly fitted footwear, podiatry referral
Second-line / adjunct
Cilostazol 100 mg PO BID for refractory claudication — phosphodiesterase 3 inhibitor; CONTRAINDICATED in heart failure
Endovascular revascularization (angioplasty + stent) — for lifestyle-limiting claudication refractory to medical therapy, or CLTI
Surgical bypass (aortobifemoral, fem-pop, fem-tibial) — for long-segment occlusion or failed endovascular therapy
Wound care and limb salvage in CLTI — vascular surgery consultation
Amputation as last resort when revascularization fails or infection threatens life
Complications
Chronic limb-threatening ischemia and limb loss
Acute limb ischemia (sudden occlusion from embolism, most often from atrial fibrillation or post-MI mural thrombus, or from in-situ thrombosis on existing PAD) — 6 P's: pain, pallor, pulselessness, paresthesia, paralysis, poikilothermia
Myocardial infarction and stroke (PAD doubles risk)
Non-healing infected wounds, sepsis
Restenosis after intervention
PANCE pearls
ABI >1.40 means non-compressible vessels (diabetes, CKD) — get a toe-brachial index instead.
Supervised exercise therapy beats most drugs for claudication distance — prescribe it like a medication.
COMPASS trial: rivaroxaban 2.5 mg BID + aspirin reduces MACE in stable atherosclerosis (CAD or PAD) at the cost of slightly increased bleeding.
Cilostazol is CONTRAINDICATED in heart failure of any severity.
Acute limb ischemia (6 P's) is a vascular emergency — heparin drip and emergent vascular consult; do not wait for imaging. Sensory loss beyond the toes with mild-to-moderate muscle weakness (Rutherford IIb, immediately threatened) needs immediate revascularization (thromboembolectomy, bypass, or catheter-directed therapy); profound anesthesia with paralysis (Rutherford III) means an irreversibly damaged limb; watch for reperfusion compartment syndrome afterward.
References
ACC/AHA 2024 PAD — 2024 ACC/AHA/AACVPR/APMA/ABC/SCAI/SVM/SVN/SVS/SIR/VESS Guideline for the Management of Lower Extremity Peripheral Artery Disease (Gornik et al., Circulation 2024)
COMPASS Trial — Rivaroxaban with or without Aspirin in Stable Cardiovascular Disease (Eikelboom et al., NEJM 2017)
VOYAGER PAD — Rivaroxaban in Peripheral Artery Disease after Revascularization (Bonaca et al., NEJM 2020)
CLEVER Trial — Supervised Exercise Versus Stent Revascularization for Aortoiliac PAD (Murphy et al., Circulation 2012)
ACC/AHA 2026 Dyslipidemia — 2026 ACC/AHA/AACVPR/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Dyslipidemia (Blumenthal, Morris et al., JACC 2026;87:2624-2757)
Practice Cardiovascular questions on FirstPassPA
Turn this outline into retention. 7,700+ board-style questions with an AI tutor that explains every answer — free to start, no card required.
Educational use only. This outline is a study aid for PA students and is not medical advice or a substitute for clinical judgment. FirstPassPA is an independent study tool and is not affiliated with, endorsed by, or sponsored by NCCPA or PAEA. PANCE® and PANRE® are registered trademarks of the National Commission on Certification of Physician Assistants; End of Rotation™ is a program of the Physician Assistant Education Association.